Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Malte Larsen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|July 9, 2019
Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degenerationTroels Brynskov, Inger Christine Munch, Tobias Malte Larsen, et al.
BMJ Open|December 15, 2021
PR interval prolongation and 1-year mortality among emergency department patients: a multicentre transnational cohort studyRune Vad, Tobias Malte Larsen, Helene Kildegaard, et al.
Ugeskrift for Laeger|November 3, 2023
Tobias Malte Larsen, Malene Barfod O'Connell, Ane Teisner, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|July 9, 2019
Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degenerationTroels Brynskov, Inger Christine Munch, Tobias Malte Larsen, et al.
BMJ Open|December 15, 2021
PR interval prolongation and 1-year mortality among emergency department patients: a multicentre transnational cohort studyRune Vad, Tobias Malte Larsen, Helene Kildegaard, et al.
Ugeskrift for Laeger|November 3, 2023
Tobias Malte Larsen, Malene Barfod O'Connell, Ane Teisner, et al.
Pageof 1